Loading your page…
Marketing-authorisation holder · Spain
147 medicines in 8 countries, as authorisation holder, manufacturer and marketer.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
1–25 of 147
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABFENTIQ 1200 MICROGRAMOS COMPRIMIDOS PARA CHUPAR EFG1,8851 mg · Comprimido para chupar | Fentanyl | Spain | Authorised | 2016 |
| ABFENTIQ 1600 MICROGRAMOS COMPRIMIDOS PARA CHUPAR EFG2,5134 mg · Comprimido para chupar | Fentanyl | Spain | Authorised | 2016 |
| ABFENTIQ 200 MICROGRAMOS COMPRIMIDOS PARA CHUPAR EFG0,3142 mg · Comprimido para chupar | Fentanyl | Spain | Marketed | 2016 |
| ABFENTIQ 400 MICROGRAMOS COMPRIMIDOS PARA CHUPAR EFG0,6284 mg · Comprimido para chupar | Fentanyl | Spain | Marketed | 2016 |
| ABFENTIQ 600 MICROGRAMOS COMPRIMIDOS PARA CHUPAR EFG0,9425 mg · Comprimido para chupar | Fentanyl | Spain | Marketed | 2016 |
| ABFENTIQ 800 MICROGRAMOS COMPRIMIDOS PARA CHUPAR EFG1,2567 mg · Comprimido para chupar | Fentanyl | Spain | Marketed | 2016 |
| ACALKA 1080 mg COMPRIMIDOS DE LIBERACION PROLONGADA1080 mg · Comprimido de liberación prolongada | Potassium | Spain | Marketed | 1993 |
| ADASUVEPolvere per inalazione, pre-dosata | Loxapine | Italy | Authorised | |
| Adasuve | Loxapine | EU (EMA) | Authorised | 2013 |
| Adasuve 4,5 mg inhalatiepoeder, voorverdeeldInhalatiepoeder, voorverdeeld | Loxapine | Netherlands | Authorised | 2013 |
| Adasuve 9,1 mg inhalatiepoeder, voorverdeeldInhalatiepoeder, voorverdeeld | Loxapine | Netherlands | Authorised | 2013 |
| ADASUVE 9,1 MG POLVO PARA INHALACION (UNIDOSIS)9,1 mg · Polvo para inhalación (unidosis) | Loxapine | Spain | Marketed | 2016 |
| ADASUVE 9,1 MG POLVO PARA INHALACION (UNIDOSIS)9,1 mg · Polvo para inhalación (unidosis) | Loxapine | Spain | Authorised | 2013 |
| ALZIL 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG10,42 mg · Comprimido recubierto con película | Rosuvastatin | Spain | Marketed | 2017 |
| ALZIL 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA15,83 mg · Comprimido recubierto con película | Rosuvastatin | Spain | Marketed | 2023 |
| ALZIL 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG20,84 mg · Comprimido recubierto con película | Rosuvastatin | Spain | Marketed | 2017 |
| ALZIL 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA31,679 mg · Comprimido recubierto con película | Rosuvastatin | Spain | Marketed | 2023 |
| ALZIL 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG5,21 mg · Comprimido recubierto con película | Rosuvastatin | Spain | Marketed | 2017 |
| ALZIL PLUS 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA10,4 mg + 10 mg · Comprimido recubierto con película | Rosuvastatin, Ezetimibe | Spain | Marketed | 2020 |
| ALZIL PLUS 20 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA20,8 mg + 10 mg · Comprimido recubierto con película | Rosuvastatin, Ezetimibe | Spain | Marketed | 2020 |
| ALZIL PLUS 40 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA41,6 mg + 10 mg · Comprimido recubierto con película | Rosuvastatin, Ezetimibe | Spain | Marketed | 2020 |
| ALZIL PLUS 5 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA5,2 mg + 10 mg · Comprimido recubierto con película | Rosuvastatin, Ezetimibe | Spain | Marketed | 2020 |
| ANGINOVAG SOLUCION PARA PULVERIZACION BUCAL1,0 mg + 0,6 mg + 0,6 mg + 4 mg + 1 mg · Solución para pulverización bucal | Decualinio, Enoxolona, Hydrocortisone, Tirotricina, Lidocaine | Spain | Marketed | 1962 |
| CAPTOR 37,5 MG/325 MG COMPRIMIDOS EFG325 mg + 37,5 mg · Comprimido | Paracetamol, Tramadol | Spain | Marketed | 2012 |
| CAPTOR 75 mg/650 mg COMPRIMIDOS75 mg + 650 mg · Comprimido | Tramadol, Paracetamol | Spain | Marketed | 2012 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 115 | 87 | 28 | CompaniesAll medicines |
| Italy | 9 | 9 | 0 | CompaniesAll medicines |
| Romania | 8 | 0 | 8 | CompaniesAll medicines |
| Netherlands | 6 | 6 | 0 | CompaniesAll medicines |
| Croatia | 4 | 4 | 0 | CompaniesAll medicines |
| European Union (EMA) | 3 | 1 | 2 | CompaniesAll medicines |
| Canada | 1 | 1 | 0 | CompaniesAll medicines |
| Saudi Arabia | 1 | 1 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.
